<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>TEDE Collection:</title>
    <link>https://tede.unioeste.br/handle/tede/515</link>
    <description />
    <pubDate>Wed, 04 Feb 2026 05:51:43 GMT</pubDate>
    <dc:date>2026-02-04T05:51:43Z</dc:date>
    <item>
      <title>AÇÃO INIBITÓRIA DE MICOCINAS PRODUZIDAS POR WICKERHAMOMYCES  ANOMALUS EM SALMONELLA MINNESOTA ISOLADAS DE CARNES DE FRANGO</title>
      <link>https://tede.unioeste.br/handle/tede/8125</link>
      <description>Title: AÇÃO INIBITÓRIA DE MICOCINAS PRODUZIDAS POR WICKERHAMOMYCES  ANOMALUS EM SALMONELLA MINNESOTA ISOLADAS DE CARNES DE FRANGO
Autor: Melin, Gabriel Antonio
Primeiro orientador: Gandra, Rinaldo Ferreira
Abstract: The export and consumption of chicken meat in Brazil have been progressively &#xD;
increasing, demanding rigorous microbiological analyses to ensure food safety. Among &#xD;
the most relevant pathogens is Salmonella minnesota, a serovar associated with &#xD;
antimicrobial resistance and frequently detected in poultry products. This study aimed to &#xD;
evaluate the production of β-1,3-glucanases by the yeast Wickerhamomyces anomalus&#xD;
and its antimicrobial activity against S. minnesota strains isolated from chicken meat. A &#xD;
total of 73 Salmonella spp. isolates were typified, of which 27 were confirmed as S. &#xD;
minnesota. The antimicrobial action of the mycocins was assessed through solid media &#xD;
and microdilution assays, with complete inhibition of all 27 strains observed at a &#xD;
concentration of 0.11 U/mg of β-glucanases present in the supernatant of the W. &#xD;
anomalus WA40 strain. The results indicate that the mycocins have potential as biocontrol &#xD;
and biopreservation agents in the poultry industry.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</description>
      <pubDate>Thu, 21 Aug 2025 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tede.unioeste.br/handle/tede/8125</guid>
      <dc:date>2025-08-21T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Potencial terapêutico dos alcaloides na redução de medidas corporais: uma revisão sistemática</title>
      <link>https://tede.unioeste.br/handle/tede/8079</link>
      <description>Title: Potencial terapêutico dos alcaloides na redução de medidas corporais: uma revisão sistemática
Autor: Silva, Robson Ricardo Oliveira da
Primeiro orientador: Sanches, Andréia Cristina  Conegero
Abstract: Obesity is a multifactorial clinical condition characterized by excessive&#xD;
accumulation of body fat and is associated with various chronic diseases. This study a&#xD;
imed togather scientific evidence on the use of alkaloids as a potential therapeutic &#xD;
approach for thetreatment of obesity through a systematic review of randomized &#xD;
clinical trials. The search was conducted in the PubMed, Scopus, Embase, and Web &#xD;
of Science data bases up to February 2025, using descriptors related to obesity and &#xD;
different types of alkaloids. Initially, 300 studies were identified, of which 291 &#xD;
wereselected for title and abstract screening. From these, 56 studies me tthe inclusion&#xD;
criteria and were fully analyzed. The average impact factor of the journals was 4.269, &#xD;
with 78.3% of the studies published in journals with an impact factor equal to or greater &#xD;
than 3. Methodological quality was assessed using the Rob2 Cochrane tool and the &#xD;
Jadad Scale, resulting in an average score of 3.15, indicating moderate to high quality.&#xD;
The results showed that 66.1% of the studies reported significant reductions in body &#xD;
measurements, while 23.2% indicated a tendency to ward reduction. Half of the studies &#xD;
(50%) includedco-interventions suchas diet and physicalactivity. The total sample &#xD;
comprised 3,286 participants, with a mean age of 35.8 years and anaverage treatment&#xD;
duration of approximately 15.8 weeks. Caffeine, aloneor in combination, was the most&#xD;
studied alkaloid, showing predominantly positive results, especially when combined &#xD;
with ephedrine. Berberine demonstrated consistent efficacy acrossall studies in which &#xD;
it was evaluated. Other alkaloids, such as theobromine, piperine, synephrine, and &#xD;
capsaicin, also showed potential for body weight reduction. In contrast, colchicinedid&#xD;
not presentrelevant clinical effects. Weight reduction ranged from 1.65% to 14.4%, &#xD;
depending on the substance or combination used. It is concluded that certain alkaloids &#xD;
may contribute to weight loss, particularly when associated with other interventions. &#xD;
How ever, further studies are necessary to confirm the safety and efficacy of these&#xD;
substances in the treatment of obesity.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</description>
      <pubDate>Thu, 14 Aug 2025 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tede.unioeste.br/handle/tede/8079</guid>
      <dc:date>2025-08-14T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Avaliação do uso de fibra obtida por eletrofiação contendo óleo de Girassol  ozonizado na cicatrização de lesões estéreis</title>
      <link>https://tede.unioeste.br/handle/tede/7974</link>
      <description>Title: Avaliação do uso de fibra obtida por eletrofiação contendo óleo de Girassol  ozonizado na cicatrização de lesões estéreis
Autor: Fabrini, Carla Diel
Primeiro orientador: Menolli, Rafael Andrade
Abstract: Ozone (O3) is a highly reactive inorganic molecule; that is part of the atmosphere and &#xD;
can also be produced by ozone generators. It is a potent microbicidal agent, having &#xD;
antibacterial, antiviral, antifungal, and antiparasitic properties, which can have its &#xD;
mechanism of action divided into three aspects: immunomodulation, antimicrobial &#xD;
activity, and ability to interact with the oxidant/antioxidant balance. In this regard, &#xD;
ozonated oil has been used topically to treat chronic wounds. The electrospinning &#xD;
technique (or electrostatic spinning) has the potential to produce materials made of &#xD;
nanofibers, and these nanofibers, when assembled, can give rise to blankets and &#xD;
membranes, presenting a large specific surface area, high porosity, and &#xD;
interconnectivity, making them suitable for the nutrient transport, cellular &#xD;
communication, and efficient cellular responses. Wound healing is a multiphase &#xD;
process consisting of three overlapping stages: inflammation, tissue proliferation, and &#xD;
remodeling. Adjuvant therapy is often required because of low healing rates in chronic &#xD;
wounds treated with standard care. Therefore, this work aims to verify the efficiency of &#xD;
ozonized Sunflower oil incorporated into electrospun fibers as a healing method in &#xD;
excisional lesions on the back of BALB/c mice. The electrospun fiber (Ecovio®) &#xD;
showed great promise in reducing the lesion, especially in the initial days (3 days). It &#xD;
was also able to significantly reduce the number of leukocytes in 7 days, showing its &#xD;
anti-inflammatory effect. Sunflower oil, whether ozonated or not, appears to bring &#xD;
greater hydration to the lesion, but further research is needed with different &#xD;
concentrations of ozone in the oil, as there have been controversial results.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</description>
      <pubDate>Wed, 11 Sep 2024 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tede.unioeste.br/handle/tede/7974</guid>
      <dc:date>2024-09-11T00:00:00Z</dc:date>
    </item>
    <item>
      <title>PELLETS DE ÁCIDO TARTÁRICO COMO NÚCLEO MODULADOR DE PH PARA FORMULAÇÕES DE CITRATO DE SILDENAFILA</title>
      <link>https://tede.unioeste.br/handle/tede/7946</link>
      <description>Title: PELLETS DE ÁCIDO TARTÁRICO COMO NÚCLEO MODULADOR DE PH PARA FORMULAÇÕES DE CITRATO DE SILDENAFILA
Autor: Bedin, Amanda Moscibroski da Silva
Primeiro orientador: Bunhak, Elcio Jose
Abstract: Pulmonary arterial hypertension (PAH) is a severe condition characterized by&#xD;
increased pressure in the pulmonary arteries, potentially leading to right heart failure.&#xD;
Sildenafil citrate (SC) is a phosphodiesterase type 5 (PDE5) inhibitor widely used in&#xD;
PAH treatment, but its low solubility and bioavailability limit its clinical efficacy.&#xD;
Therefore, this study aimed to develop a multiparticulate controlled-release&#xD;
formulation of SC, using tartaric acid pellets as the core, solid dispersion, and&#xD;
factorial design to optimize its dissolution and absorption. The methodology involved&#xD;
preparing SC solid dispersions using the Soluplus ® polymer and Tween ® 80&#xD;
surfactant, followed by incorporating these dispersions into tartaric acid pellets&#xD;
coated with controlled-release polymers. An experimental design (DOE) was applied&#xD;
to assess the influence of variables on drug dissolution. The formulations were&#xD;
characterized using differential scanning calorimetry (DSC), X-ray diffraction (XRD),&#xD;
particle size distribution (PSD), scanning electron microscopy (SEM), and in vitro&#xD;
dissolution analysis with quantification by high-performance liquid chromatography&#xD;
(HPLC). The results demonstrated that solid dispersion significantly improved SC&#xD;
dissolution, and the coated pellets exhibited an adequate controlled-release profile,&#xD;
maintaining drug stability in biological media. Dissolution studies in FaSSIF buffer&#xD;
(pH 6.5) confirmed a gradual SC release, enhancing its absorption in the&#xD;
gastrointestinal tract and improving therapeutic efficacy. Thus, the use of tartaric acid&#xD;
pellets and solid dispersions proved to be a promising strategy to enhance SC’s oral&#xD;
bioavailability and optimize its clinical performance in PAH treatment. This innovative&#xD;
approach may contribute to the development of more effective pharmaceutical&#xD;
formulations, reducing the need for frequent dosing and improving patient adherence&#xD;
to treatment.
Publisher: Universidade Estadual do Oeste do Paraná
Tipo do documento: Dissertação</description>
      <pubDate>Tue, 18 Mar 2025 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://tede.unioeste.br/handle/tede/7946</guid>
      <dc:date>2025-03-18T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

